Innospec Inc.
General ticker "IOSP" information:
- Sector: Materials
- Industry: Chemicals - Specialty
- Capitalization: $1.9B (TTM average)
Innospec Inc. follows the US Stock Market performance with the rate: 54.6%.
Estimated limits based on current volatility of 0.9%: low 96.08$, high 97.78$
Factors to consider:
- Company pays dividends (semi-annually): last record date 2026-05-19, amount 0.92$ (Y1.90%)
- Total employees count: 2450 (0.0%) as of 2025
- US accounted for 56.3% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Geopolitical risks, Raw material costs, Customer concentration, Regulatory and compliance, Cybersecurity threats
- Earnings for 6 months up through Q2 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [61.37$, 91.98$]
- 2026-12-31 to 2027-12-31 estimated range: [65.83$, 97.07$]
Financial Metrics affecting the IOSP estimates:
- Positive: with PPE of 14.7 at the end of fiscal year the price was neutral
- Positive: 4.60 < Operating profit margin, % of 7.28
- Positive: 6.77 < Operating cash flow per share per price, % of 7.13
- Negative: Investing cash flow per share per price, % of -3.87 <= -2.60
- Positive: Interest expense per share per price, % of 0 <= 0
- Negative: Industry earnings per price (median), % of 2.85 <= 3.58
- Positive: 69.38 < Shareholder equity ratio, % of 72.37 <= 81.92
- Negative: Industry operating profit margin (median), % of 1.52 <= 2.92
- Positive: Industry inventory ratio change (median), % of -0.11 <= 0
Short-term IOSP quotes
Long-term IOSP plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1,948.80MM | $1,845.60MM | $1,778.20MM |
| Operating Expenses | $1,787.20MM | $1,667.70MM | $1,648.70MM |
| Operating Income | $161.60MM | $177.90MM | $129.50MM |
| Non-Operating Income | $12.80MM | $-136.70MM | $8.60MM |
| R&D Expense | $49.00MM | $56.50MM | $51.00MM |
| Income(Loss) | $174.40MM | $41.20MM | $138.10MM |
| Taxes | $35.30MM | $5.60MM | $21.50MM |
| Net Income(Loss)* | $139.10MM | $35.60MM | $116.60MM |
| Stockholders Equity | $1,147.10MM | $1,211.20MM | $1,326.10MM |
| Inventory | $300.10MM | $301.00MM | $329.30MM |
| Assets | $1,707.40MM | $1,734.70MM | $1,832.40MM |
| Operating Cash Flow | $207.30MM | $184.50MM | $138.30MM |
| Capital expenditure | $62.10MM | $41.40MM | $50.30MM |
| Investing Cash Flow | $-111.80MM | $-62.00MM | $-75.10MM |
| Financing Cash Flow | $-39.00MM | $-35.30MM | $-63.90MM |
| Earnings Per Share** | $5.60 | $1.43 | $4.69 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.